The naturally occurring aliphatic isothiocyanates sulforaphane and erucin are weak agonists but potent non-competitive antagonists of the aryl hydrocarbon receptor.
Ahmad F Abdull Razis, Natalya Hanlon, Ewa Soltys, Veronika Krizova, Renato Iori, Kathryn E Plant, Nick Plant, Costas Ioannides
Index: Arch. Toxicol. 86(10) , 1505-14, (2012)
Full Text: HTML
Abstract
As the Ah receptor target gene products play a critical role in chemical carcinogenesis, antagonists are considered as potential chemopreventive agents. It is demonstrated in this paper that the isothiocyanates R,S-sulforaphane and erucin are non-competitive antagonists of the aryl hydrocarbon (Ah) receptor. Both isothiocyanates were poor agonists for the receptor and elevated CYP1A1 mRNA levels only modestly when incubated with precision-cut rat liver slices. In contrast, the classical Ah receptor agonist benzo[a]pyrene was a potent inducer of CYP1A1 mRNA levels, with this effect being effectively antagonized by the two isothiocyanates. In further studies, it was demonstrated that R,S-sulforaphane could both prevent the interaction of and displace already bound benzo[a]pyrene from the Ah receptor, but no concentration dependency was observed with respect to the isothiocyanate. Both erucin and R,S-sulforaphane antagonized the benzo[a]pyrene-mediated increase in the CYP1A-mediated O-deethylation of ethoxyresorufin in rat precision-cut liver slices. Of the two isomers of R,S-sulforaphane, the naturally occurring R-isomer was more effective than the S-isomer in antagonizing the activation of the Ah receptor by benzo[a]pyrene. Antagonism of the Ah receptor may be a major contributor to the established chemoprevention of aliphatic isothiocyanates.
Related Compounds
Related Articles:
The licorice flavonoid isoliquiritigenin reduces DNA-binding activity of AhR in MCF-7 cells.
2014-09-25
[Chem. Biol. Interact. 221 , 70-6, (2014)]
2011-01-01
[Drug Metab. Lett. 5(1) , 6-16, (2011)]
2011-01-01
[Drug Metab. Dispos. 39(1) , 83-91, (2011)]
2011-03-01
[Lung Cancer 71(3) , 298-305, (2011)]
2011-02-01
[Biochem. Pharmacol. 81(3) , 442-50, (2011)]